Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 20/20 | 0.70 |
| ▸ | ITGAV | P06756 | 20/20 | 0.70 |
| ▸ | ITGA2B | P08514 | 19/20 | 0.70 |
| ▸ | ITGB1 | P05556 | 2/20 | 0.52 |
| ▸ | ITGA5 | P08648 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL7403171 | 0.96 | ITGB3 (0.65) | ITGB3ITGAVITGA2BITGB1ITGA5 | |
| SCHEMBL7407597 | 0.95 | ITGB3 (0.69) | ITGB3ITGAVITGA2BITGB1ITGA5 | |
| SCHEMBL7982597 | 0.93 | ITGB3 (0.71) | ITGB3ITGAVITGA2B | |
| SCHEMBL7401670 | 0.90 | ITGB3 (0.70) | ITGB3ITGAVITGA2BITGB1ITGA5 | |
| SCHEMBL7404741 | 0.88 | ITGB3 (0.55) | ITGB3ITGAVITGA2B | |
| SCHEMBL7401808 | 0.88 | ITGB3 (0.70) | ITGB3ITGAVITGA2B | |
| SCHEMBL7986014 | 0.88 | ITGB3 (0.67) | ITGB3ITGAVITGA2BITGB1ITGA5 | |
| SCHEMBL7404638 | 0.87 | ITGB3 (0.69) | ITGB3ITGAVITGA2B | |
| SCHEMBL7397410 | 0.87 | ITGB3 (0.53) | ITGB3ITGAVITGA2B | |
| SCHEMBL7969265 | 0.87 | ITGB3 (0.72) | ITGB3ITGAVITGA2BITGB1ITGA5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1996037492-A1 | ISOXAZOLINE AND ISOXAZOLE DERIVATIVES AS INTEGRIN RECEPTOR ANTAGONISTS | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1996-11-28 | — | — | WO | claimed |
| US-6214834-B1 | ANGIOGENESIS INHIBITORS; ANTIINFLAMMATORY AGENTS; ANTICANCER AGENTS | DUPONT PHARMACEUTICALS COMPANY | 2001-04-10 | — | — | US | disclosed |
| WO-1996037492-A1 | ISOXAZOLINE AND ISOXAZOLE DERIVATIVES AS INTEGRIN RECEPTOR ANTAGONISTS | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1996-11-28 | — | — | WO | disclosed |